The primary objective of this study is to evaluate the safety and efficacy of adalimumab for the treatment of cutaneous sarcoidosis. A secondary objective is to study gene expression in sarcoidosis.
The purpose of the study is to see if Humira is effective and safe in the treatment of sarcoidosis.